• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化学致癌作用的分子机制:癌基因与肿瘤抑制基因的作用

Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.

作者信息

Stanley L A

机构信息

Department of Pharmacology, University of Oxford, UK.

出版信息

Toxicology. 1995 Feb 27;96(3):173-94. doi: 10.1016/0300-483x(94)02991-3.

DOI:10.1016/0300-483x(94)02991-3
PMID:7900159
Abstract

The observation that oncogenes are frequently activated in human tumours raises the question of whether these genes are involved in chemical carcinogenesis. H-ras activation is probably an initiating event in mouse skin and rat mammary gland systems. The H-ras oncogene is also important in mouse liver tumours; in mouse lung the K-ras gene is commonly activated. In both, the mutations observed are usually those predicted from the adduct-forming properties of the carcinogen. Among non-ras oncogenes, only raf and neu have been detected in experimental tumours. Tumour suppressor genes are frequently inactivated in human tumours. Searches for such phenomena in animal tumours have generally had disappointing results. p53 and Rb gene alterations are rarely observed in chemically-induced tumours. The reason may be that unknown tumour suppressor genes are involved in animal tumour development. Several novel genes have been identified using animal tumour susceptibility models. Thus, ras genes are important in chemical carcinogenesis, but as the methodology for studying other genes improves, their roles will be seen in perspective.

摘要

致癌基因在人类肿瘤中经常被激活这一现象,引发了这些基因是否参与化学致癌过程的问题。H-ras激活可能是小鼠皮肤和大鼠乳腺系统中的一个起始事件。H-ras致癌基因在小鼠肝癌中也很重要;在小鼠肺癌中,K-ras基因通常被激活。在这两种情况下,观察到的突变通常是根据致癌物的加合物形成特性预测的那些突变。在非ras致癌基因中,只有raf和neu在实验性肿瘤中被检测到。肿瘤抑制基因在人类肿瘤中经常失活。在动物肿瘤中寻找此类现象的研究通常结果令人失望。在化学诱导的肿瘤中很少观察到p53和Rb基因改变。原因可能是未知的肿瘤抑制基因参与了动物肿瘤的发展。使用动物肿瘤易感性模型已经鉴定出了几个新基因。因此,ras基因在化学致癌过程中很重要,但随着研究其他基因的方法的改进,它们的作用将得到正确看待。

相似文献

1
Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes.化学致癌作用的分子机制:癌基因与肿瘤抑制基因的作用
Toxicology. 1995 Feb 27;96(3):173-94. doi: 10.1016/0300-483x(94)02991-3.
2
Role of proto-oncogene activation in carcinogenesis.原癌基因激活在致癌作用中的作用。
Environ Health Perspect. 1992 Nov;98:13-24. doi: 10.1289/ehp.929813.
3
Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.C57BL/6×C3H F1小鼠自发产生的非肝脏肿瘤中原癌基因的激活。
Cancer Res. 1991 Feb 15;51(4):1148-53.
4
Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.N-亚硝基二乙胺诱导的小鼠肝癌和4-(甲基亚硝基氨基)-1-(3-吡啶基)-1-丁酮诱导的小鼠肺癌中的剂量依赖性ras突变谱
Carcinogenesis. 1993 Aug;14(8):1603-8. doi: 10.1093/carcin/14.8.1603.
5
Genetic alterations in HCA-induced tumors.HCA诱导的肿瘤中的基因改变。
Princess Takamatsu Symp. 1995;23:281-91.
6
Mutation patterns in non-ras oncogenes and tumour suppressor genes in experimentally induced tumours.实验诱导肿瘤中非Ras癌基因和肿瘤抑制基因的突变模式。
IARC Sci Publ. 1999(146):87-122.
7
Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.在暴露于1,3 - 丁二烯诱导的C57BL / 6 X C3H F1小鼠肿瘤中,密码子13突变导致K - ras激活。
Cancer Res. 1990 Aug 1;50(15):4818-23.
8
Contrasting incidence of ras mutations in rat mammary and mouse skin tumors induced by anti-benzo[c]phenanthrene-3,4-diol-1,2-epoxide.抗苯并[c]菲-3,4-二醇-1,2-环氧化物诱导的大鼠乳腺肿瘤和小鼠皮肤肿瘤中ras突变的发生率对比
Carcinogenesis. 1994 Oct;15(10):2113-6. doi: 10.1093/carcin/15.10.2113.
9
Molecular alterations in oncogenes or tumor suppressor genes during chemical carcinogenesis.化学致癌过程中原癌基因或肿瘤抑制基因的分子改变。
Prog Histochem Cytochem. 1991;23(1-4):100-6. doi: 10.1016/s0079-6336(11)80174-9.
10
Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.在乙型肝炎病毒转基因小鼠的肝癌发生过程中,多个癌基因和肿瘤抑制基因在结构和功能上保持完整。
Cancer Res. 1992 May 15;52(10):2823-9.

引用本文的文献

1
Pulmonary Inflammation and KRAS Mutation in Lung Cancer.肺癌中的肺部炎症和 KRAS 突变。
Adv Exp Med Biol. 2021;1303:71-87. doi: 10.1007/978-3-030-63046-1_5.
2
BRG1 and BRM loss selectively impacts RB and P53, respectively: BRG1 and BRM have differential functions .BRG1和BRM缺失分别选择性地影响RB和P53:BRG1和BRM具有不同的功能。
Oncoscience. 2016 Dec 21;3(11-12):337-350. doi: 10.18632/oncoscience.333. eCollection 2016.
3
Novel KRAS gene mutations in sporadic colorectal cancer.散发性结直肠癌中的新型KRAS基因突变
PLoS One. 2014 Nov 20;9(11):e113350. doi: 10.1371/journal.pone.0113350. eCollection 2014.
4
Carcinogenic ability of possibly through oncogenic mutation of gene.致癌能力可能是通过基因的致癌突变实现的。 (你提供的原文似乎不完整,翻译出来的句子逻辑上不太通顺,你可以检查下原文是否准确完整。)
Adv Cancer Res Treat. 2013 Apr 28;2013.
5
Plant phenolics: extraction, analysis and their antioxidant and anticancer properties.植物酚类:提取、分析及其抗氧化和抗癌特性。
Molecules. 2010 Oct 21;15(10):7313-52. doi: 10.3390/molecules15107313.
6
Involvement of oxidatively damaged DNA and repair in cancer development and aging.氧化性 DNA 损伤与修复在癌症发生和衰老中的作用。
Am J Transl Res. 2010 May 15;2(3):254-84.
7
Physical activity and cancer prevention : pathways and targets for intervention.身体活动与癌症预防:干预途径与靶点
Sports Med. 2008;38(4):271-96. doi: 10.2165/00007256-200838040-00002.
8
DNA-protein crosslinks and p53 protein expression in relation to occupational exposure to formaldehyde.与职业性接触甲醛相关的DNA-蛋白质交联及p53蛋白表达
Occup Environ Med. 2003 Jun;60(6):403-9. doi: 10.1136/oem.60.6.403.
9
Topographic analysis of K- ras mutations in histologically normal lung tissues and tumours of lung cancer patients.肺癌患者组织学正常肺组织及肿瘤中K-ras突变的拓扑分析
Br J Cancer. 2001 Jul 20;85(2):235-41. doi: 10.1054/bjoc.2001.1913.
10
Diminished energy metabolism and enhanced apoptosis in livers of B6C3F1 mice treated with the antihepatocarcinogen rotenone.用抗肝癌致癌物鱼藤酮处理的B6C3F1小鼠肝脏中能量代谢减弱和细胞凋亡增强。
Mol Cell Biochem. 1999 Nov;201(1-2):25-32. doi: 10.1023/a:1007024905046.